These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8608425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL.
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [Abstract] [Full Text] [Related]

  • 5. Conjugate vaccines against group B Streptococcus types IV and VII.
    Paoletti LC, Kasper DL.
    J Infect Dis; 2002 Jul 01; 186(1):123-6. PubMed ID: 12089673
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
    Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, Hickman ME, Kasper DL.
    J Infect Dis; 1999 Jan 01; 179(1):142-50. PubMed ID: 9841833
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC, Wessels MR, Michon F, DiFabio J, Jennings HJ, Kasper DL.
    Infect Immun; 1992 Oct 01; 60(10):4009-14. PubMed ID: 1398913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
    Brigtsen AK, Kasper DL, Baker CJ, Jennings HJ, Guttormsen HK.
    J Infect Dis; 2002 May 01; 185(9):1277-84. PubMed ID: 12001045
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.
    Baker CJ, Rench MA, Fernandez M, Paoletti LC, Kasper DL, Edwards MS.
    J Infect Dis; 2003 Jul 01; 188(1):66-73. PubMed ID: 12825173
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C, Kasper DL, Paoletti LC, Madoff LC.
    Infect Immun; 1999 May 01; 67(5):2491-6. PubMed ID: 10225912
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.